Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study-Reference-Cited by-同舟云学术

Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study

Published:2015-04-25 Issue:7 Volume:30 Page:912-918
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Mamikonyan Eugenia¹,Xie Sharon X.²,Melvin Emilie³,Weintraub Daniel¹⁴

Affiliation:

1. Department of Psychiatry; Perelman School of Medicine at the University of Pennsylvania; Philadelphia USA

2. Department of Biostatistics and Epidemiology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia USA

3. Duke University; Durham North Carolina USA

4. Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center; Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.26236/fullpdf

Reference46 articles.

1. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study;Aarsland;Arch Neurol,2003

2. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force Guidelines;Litvan;Mov Disord,2012

3. Mild cognitive impairment in Parkinson's disease: a multicenter pooled analysis;Aarsland;Neurology,2010

4. Effect of psychiatric and other non-motor symptoms on disability in Parkinson's disease;Weintraub;J Am Geriatr Soc,2004

5. The Priamo Study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease;Barone;Mov Disord,2009

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of acetylcholinesterase enzyme inhibitor rivastigmine on spike-wave discharges, learning-memory, anxiety, and TRPV1 channel expression in genetic absence epileptic WAG/Rij rats;2024-08-06

2. Cognition and Activity of Daily Living Function in people with Parkinson’s disease;Journal of Neural Transmission;2024-07-08

3. A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms;International Review of Neurobiology;2024

4. Enhanced Parkinson’s gait, reduced fall risk, and improved cognitive function through multimodal rehabilitation combined with rivastigmine treatment;American Journal of Translational Research;2024

5. The effects of rivastigmine on neuropsychiatric symptoms in the early stages of Parkinson's disease: A systematic review;European Journal of Neurology;2023-11-17